Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth (Genetics in Medicine, (2021), 23, 5, (927-933), 10.1038/s41436-020-01073-x)

Yu Chung Lin, Katherine Keenan, Jiafen Gong, Naim Panjwani, Julie Avolio, Fan Lin, Damien Adam, Paula Barrett, Stéphanie Bégin, Yves Berthiaume, Lara Bilodeau, Candice Bjornson, Janna Brusky, Caroline Burgess, Mark Chilvers, Raquel Consunji-Araneta, Guillaume Côté-Maurais, Andrea Dale, Christine Donnelly, Lori FairserviceKatie Griffin, Natalie Henderson, Angela Hillaby, Daniel Hughes, Shaikh Iqbal, Jennifer Itterman, Mary Jackson, Emma Karlsen, Lorna Kosteniuk, Lynda Lazosky, Winnie Leung, Valerie Levesque, Émilie Maille, Dimas Mateos-Corral, Vanessa McMahon, Mays Merjaneh, Nancy Morrison, Michael Parkins, Jennifer Pike, April Price, Bradley S. Quon, Joe Reisman, Clare Smith, Mary Jane Smith, Nathalie Vadeboncoeur, Danny Veniott, Terry Viczko, Pearce Wilcox, Richard van Wylick, Garry Cutting, Elizabeth Tullis, Felix Ratjen, Johanna M. Rommens, Lei Sun, Melinda Solomon, Anne L. Stephenson, Emmanuelle Brochiero, Scott Blackman, Harriet Corvol, Lisa J. Strug

Research output: Contribution to journalComment/debatepeer-review

Abstract

The risk alleles of rs1964986 (PRSS1) and rs959173 (CAV1) should be the C allele for both variants instead of the A and T alleles listed in the paper. The changes have been reflected in both Figure 1 and Table 2 shown below.

Original languageEnglish (US)
Pages (from-to)2235-2236
Number of pages2
JournalGenetics in Medicine
Volume23
Issue number11
DOIs
StatePublished - Nov 2021

ASJC Scopus subject areas

  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth (Genetics in Medicine, (2021), 23, 5, (927-933), 10.1038/s41436-020-01073-x)'. Together they form a unique fingerprint.

Cite this